Drug Type Small molecule drug |
Synonyms PKS 21221 |
Target |
Mechanism PSMB8 inhibitors(proteasome 20S subunit beta 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC30H34F2N4O5S |
InChIKeySAQXBNSPOWSONB-SANMLTNESA-N |
CAS Registry2095522-25-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Discovery | US | 06 Jan 2023 |